Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
ENDRA Life Sciences Inc. (NDRA) had Weighted-Average Shares Outstanding (Diluted) of 6.36M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-10.06M |
|
-- |
|
-- |
|
$10.52M |
|
$-10.52M |
|
$0.46M |
|
$-10.06M |
|
$-10.06M |
|
$-10.06M |
|
$-10.06M |
|
$-10.06M |
|
$-10.06M |
|
$-10.52M |
|
$-10.25M |
|
6.36M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
6.36M |
$-1.58 |
|
$-1.58 |
|
| Balance Sheet Financials | |
$5.66M |
|
$0.11M |
|
$1.10M |
|
$6.75M |
|
$0.90M |
|
-- |
|
$0.19M |
|
$1.10M |
|
$5.66M |
|
$5.66M |
|
$5.66M |
|
10.39M |
|
| Cash Flow Statement Financials | |
$-9.55M |
|
$-0.02M |
|
$7.52M |
|
$4.89M |
|
$2.83M |
|
$-2.06M |
|
$1.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.26 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.57M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-177.77% |
|
-177.77% |
|
-148.95% |
|
-177.77% |
|
$0.54 |
|
$-1.50 |
|
$-1.50 |
|